Optical image-guided cancer therapy

Current Pharmaceutical Biotechnology

Volumn 14, Issue 8, 2013, Pages 723-732

  Bu, Lihong ^a,b   Ma, Xiaowei ^a   Tu, Yingfeng ^a,b   Shen, Baozhong ^b   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Bioluminescence imaging (bli); Cerenkov luminescence imaging; Fluorescence imaging; Image guided cancer therapy; Molecular imaging; Optical imaging

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; NANOPARTICLE; PROTEIN P53;

ARTICLE; BIOLUMINESCENCE; CANCER GENE THERAPY; CANCER THERAPY; CELL TRACKING; CERENKOV LUMINESCENCE IMAGING; FLUORESCENCE IMAGING; GENE EXPRESSION; HUMAN; IMAGING; IMMUNOCOMPETENT CELL; MOLECULAR IMAGING; MONITORING; NEOPLASM; NONHUMAN; SAFETY; SENTINEL LYMPH NODE;

ANIMALS; HUMANS; LUMINESCENCE; NEOPLASMS; OPTICAL IMAGING;

EID: 84893508302     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201014666131226112507     Document Type: Article

References (98)

1. Antman, K.H. New developments in clinical oncology: The interdependence of bench and bedside. Cancer Res., 1991, 51, 5060s-5064s.
2. Joseph, S.O.; Wu, J.; Muggia, F.M. Targeted therapy: Its status and promise in selected solid tumors. Part II: Impact on selected tumor subsets, and areas of evolving integration. Oncology (Williston Park), 2012, 26, 1021-1030, 1035.
3. Awada, A.; Aftimos, P.G. Targeted therapies of solid cancers: New options, new challenges. Curr. Opin. Oncol., 2013, 25, 296-304.
4. Vosburgh, K.G.; Jolesz, F.A. The concept of image-guided therapy. Acad. Radiol, 2003, 10, 176-179.
5. Kim, J.; Jin, J.Y.; Walls, N.; Nurushev, T.; Movsas, B.; Chetty, I.J.; Ryu, S. Image-guided localization accuracy of stereoscopic planar and volumetric imaging methods for stereotactic radiation surgery and stereotactic body radiation therapy: A phantom study. Int. J. Radiat. Oncol. Biol. Phys., 2011, 79, 1588-1596.
6. Muller, J.; Wunder, A.; Licha, K. Optical imaging. Rec.Results Cancer Res., 2013, 187, 221-246.
7. DeLuca, M.; McElroy, W.D. Kinetics of the firefly luciferase catalyzed reactions. Biochemistry, 1974, 13, 921-925.
8. Kelkar, M.; De, A. Bioluminescence based in vivo screening technologies. Curr. Opin. Pharmacol., 2012, 12, 592-600.
9. Luker, K.E.; Luker, G.D. Applications of bioluminescence imaging to antiviral research and therapy: Multiple luciferase enzymes and quantitation. Antiviral Res., 2008, 78, 179-187.
10. de Wet, J.R.; Wood, K.V.; Helinski, D.R.; DeLuca, M. Cloning of firefly luciferase cDNA and the expression of active luciferase in escherichia coli. Proc. Natl. Acad. Sci. USA, 1985, 82, 7870-7873.
11. Tuli, R.; Surmak, A.; Reyes, J.; Hacker-Prietz, A.; Armour, M.; Leubner, A.; Blackford, A.; Tryggestad, E.; Jaffee, E.M.; Wong, J.; Deweese, T.L.; Herman, J.M. Development of a novel preclinical pancreatic cancer research model: Bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenografts. Transl. Oncol., 2012, 5, 77-84.
12. Thompson, S.M.; Callstrom, M.R.; Knudsen, B.E.; Anderson, J.L.; Sutor, S.L.; Butters, K.A.; Kuo, C.; Grande, J.P.; Roberts, L.R.; Woodrum, D.A. Molecular bioluminescence imaging as a noninvasive tool for monitoring tumor growth and therapeutic response to MRI-guided laser ablation in a rat model of hepatocellular carcinoma. Invest. Radiol., 2013, 48, 413-421.
13. Au, J.T.; Gonzalez, L.; Chen, C.H.; Serganova, I.; Fong, Y. Bioluminescence imaging serves as a dynamic marker for guiding and assessing thermal treatment of cancer in a preclinical model. Ann. Surg. Oncol., 2012, 19, 3116-3122.
14. Wender, P.A.; Goun, E.A.; Jones, L.R.; Pillow, T.H.; Rothbard, J.B.; Shinde, R.; Contag, C.H. Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice. Proc. Natl. Acad. Sci. USA, 2007, 104, 10340-10345.
15. Roth, J.A.; Cristiano, R.J. Gene therapy for cancer: What have we done and where are we going? J. Natl. Cancer Inst., 1997, 89, 21-39.
16. Iyer, M.; Sato, M.; Johnson, M.; Gambhir, S.S.; Wu, L. Applications of molecular imaging in cancer gene therapy. Curr. Gene Ther., 2005, 5, 607-618.
17. Bykov, V.J.; Issaeva, N.; Shilov, A.; Hultcrantz, M.; Pugacheva, E.; Chumakov, P.; Bergman, J.; Wiman, K.G.; Selivanova, G. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nat. Med., 2002, 8, 282-288.
18. Lisiansky, V.; Naumov, I.; Shapira, S.; Kazanov, D.; Starr, A.; Arber, N.; Kraus, S. Gene therapy of pancreatic cancer targeting the K-Ras oncogene. Cancer Gene Ther., 2012, 19, 862-869.
19. Hatanaka, K.; Suzuki, K.; Miura, Y.; Yoshida, K.; Ohnami, S.; Kitade, Y.; Yoshida, T.; Aoki, K. Interferon-alpha and antisense Kras RNA combination gene therapy against pancreatic cancer. J. Gene Med., 2004, 6, 1139-1148.
20. Wang, W.; El-Deiry, W.S. Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model. Cancer Biol. Ther., 2003, 2, 196-202.
21. Qiao, J.; Doubrovin, M.; Sauter, B.V.; Huang, Y.; Guo, Z.S.; Balatoni, J.; Akhurst, T.; Blasberg, R.G.; Tjuvajev, J.G.; Chen, S.H.; Woo, S.L. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther., 2002, 9, 168-175.
22. Massoud, T.F.; Gambhir, S.S. Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev., 2003, 17, 545-580.
23. Soling, A.; Theiss, C.; Jungmichel, S.; Rainov, N.G. A dual function fusion protein of herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet Vaccines Ther., 2004, 2, 7.
24. Jang, S.J.; Kang, J.H.; Kim, K.I.; Lee, T.S.; Lee, Y.J.; Lee, K.C.; Woo, K.S.; Chung, W.S.; Kwon, H.C.; Ryu, C.J.; Choi, T.H.; Choi, C.W.; Lim, S.M.; Cheon, G.J. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma. Cancer Lett., 2010, 297, 84-90.
25. Iyer, M.; Berenji, M.; Templeton, N.S.; Gambhir, S.S. Noninvasive imaging of cationic lipid-mediated delivery of optical and PET reporter genes in living mice. Mol. Ther., 2002, 6, 555-562.
26. Hong, H.; Yang, Y.; Zhang, Y.; Cai, W. Non-invasive cell tracking in cancer and cancer therapy. Curr. Top Med. Chem., 2010, 10, 1237-1248.
27. Riviere, I.; Sadelain, M.; Brentjens, R.J. Novel strategies for cancer therapy: The potential of genetically modified T lymphocytes. Curr. Hematol. Rep., 2004, 3, 290-297.
28. Prins, R.M.; Shu, C.J.; Radu, C.G.; Vo, D.D.; Khan-Farooqi, H.; Soto, H.; Yang, M.Y.; Lin, M.S.; Shelly, S.; Witte, O.N.; Ribas, A.; Liau, L.M. Anti-tumor activity and trafficking of self, tumorspecific T cells against tumors located in the brain. Cancer Immunol. Immunother., 2008, 57, 1279-1289.
29. Wang, H.; Cao, F.; De, A.; Cao, Y.; Contag, C.; Gambhir, S.S.; Wu, J.C.; Chen, X. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells, 2009, 27, 1548-1558.
30. Keereweer, S.; Van Driel, P.B.; Snoeks, T.J.; Kerrebijn, J.D.; Baatenburg de Jong, R.J.; Vahrmeijer, A.L.; Sterenborg, H.J.; Lowik, C.W. Optical image-guided cancer surgery: Challenges and limitations. Clin. Cancer. Res., 2013, 19, 3745-3754.
31. Frangioni, J.V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol., 2003, 7, 626-634.
32. Rasmussen-Taxdal, D.S.; Ward, G.E.; Figge, F.H. Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Surg. Forum, 1955, 5, 619-624.
33. Patterson, M.S.; Chance, B.; Wilson, B.C. Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties. Appl. Opt., 1989, 28, 2331-2336.
34. Tanaka, E.; Chen, F.Y.; Flaumenhaft, R.; Graham, G.J.; Laurence, R.G.; Frangioni, J.V. Real-time assessment of cardiac perfusion, coronary angiography, and acute intravascular thrombi using dualchannel near-infrared fluorescence imaging. J. Thorac Cardiovasc. Surg., 2009, 138, 133-140.
35. Deja, M.; Ahlers, O.; Macguill, M.; Wust, P.; Hildebrandt, B.; Riess, H.; Kerner, T. Changes in hepatic blood flow during whole body hyperthermia. Int. J. Hyperthermia, 2010, 26, 95-100.
36. Hatada, A.; Okamura, Y.; Kaneko, M.; Hisaoka, T.; Yamamoto, S.; Hiramatsu, T.; Nishimura, Y. Comparison of the waveforms of transit-time flowmetry and intraoperative fluorescence imaging for assessing coronary artery bypass graft patency. Gen. Thorac Cardiovasc. Surg., 2011, 59, 14-18.
37. Balacumaraswami, L.; Abu-Omar, Y.; Choudhary, B.; Pigott, D.; Taggart, D.P. A comparison of transit-time flowmetry and intraoperative fluorescence imaging for assessing coronary artery bypass graft patency. J. Thorac. Cardiovasc. Surg., 2005, 130, 315- 320.
38. Yokoyama, N.; Otani, T.; Hashidate, H.; Maeda, C.; Katada, T.; Sudo, N.; Manabe, S.; Ikeno, Y.; Toyoda, A.; Katayanagi, N. Realtime detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: Preliminary results of a prospective study. Cancer, 2012, 118, 2813-2819.
39. Ishizawa, T.; Fukushima, N.; Shibahara, J.; Masuda, K.; Tamura, S.; Aoki, T.; Hasegawa, K.; Beck, Y.; Fukayama, M.; Kokudo, N. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer, 2009, 115, 2491-2504.
40. Yokoyama, J.; Fujimaki, M.; Ohba, S.; Anzai, T.; Yoshii, R.; Ito, S.; Kojima, M.; Ikeda, K. A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging. Onco. Targets Ther., 2013, 6, 325-330.
41. Gilmore, D.M.; Khullar, O.V.; Jaklitsch, M.T.; Chirieac, L.R.; Frangioni, J.V.; Colson, Y.L. Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using nearinfrared imaging. J. Thorac. Cardiovasc Surg., 2013,
42. Schaafsma, B.E.; Verbeek, F.P.; Rietbergen, D.D.; van der Hiel, B.; van der Vorst, J.R.; Liefers, G.J.; Frangioni, J.V.; van de Velde, C.J.; van Leeuwen, F.W.; Vahrmeijer, A.L. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br. J. Surg., 2013, 100, 1037-1044.
43. Mieog, J.S.; Troyan, S.L.; Hutteman, M.; Donohoe, K.J.; van der Vorst, J.R.; Stockdale, A.; Liefers, G.J.; Choi, H.S.; Gibbs-Strauss, S.L.; Putter, H.; Gioux, S.; Kuppen, P.J.; Ashitate, Y.; Lowik, C.W.; Smit, V.T.; Oketokoun, R.; Ngo, L.H.; van de Velde, C.J.; Frangioni, J.V.; Vahrmeijer, A.L. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann. Surg. Oncol., 2011, 18, 2483-2491.
44. Crane, L.M.; Themelis, G.; Pleijhuis, R.G.; Harlaar, N.J.; Sarantopoulos, A.; Arts, H.J.; van der Zee, A.G.; Ntziachristos, V.; van Dam, G.M. Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol. Imaging. Biol., 2011, 13, 1043-1049.
45. Schaafsma, B.E.; Mieog, J.S.; Hutteman, M.; van der Vorst, J.R.; Kuppen, P.J.; Lowik, C.W.; Frangioni, J.V.; van de Velde, C.J.; Vahrmeijer, A.L. The clinical use of indocyanine green as a nearinfrared fluorescent contrast agent for image-guided oncologic surgery. J. Surg. Oncol., 2011, 104, 323-332.
46. Gilmore, D.M.; Khullar, O.V.; Gioux, S.; Stockdale, A.; Frangioni, J.V.; Colson, Y.L.; Russell, S.E. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann. Surg. Oncol., 2013, 20, 2357-2363.
47. Su, X.; Cheng, K.; Wang, C.; Xing, L.; Wu, H.; Cheng, Z. Imageguided resection of malignant gliomas using fl uorescent nanoparticles. Wiley Interdiscip Rev. Nanomed Nanobiotechnol., 2013, 5, 219-232.
48. Li, Y.; Rey-Dios, R.; Roberts, D.W.; Valdes, P.A.; Cohen-Gadol, A.A. Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies. World Neurosurg., 2013,
49. van Dam, G.M.; Themelis, G.; Crane, L.M.; Harlaar, N.J.; Pleijhuis, R.G.; Kelder, W.; Sarantopoulos, A.; de Jong, J.S.; Arts, H.J.; van der Zee, A.G.; Bart, J.; Low, P.S.; Ntziachristos, V. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: First in-human results. Nat. Med., 2011, 17, 1315-1319.
50. Foster, A.E.; Kwon, S.; Ke, S.; Lu, A.; Eldin, K.; Sevick-Muraca, E.; Rooney, C.M. In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye. Appl. Opt., 2008, 47, 5944-5952.
51. Swirski, F.K.; Berger, C.R.; Figueiredo, J.L.; Mempel, T.R.; von Andrian, U.H.; Pittet, M.J.; Weissleder, R. A near-infrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses. Plos One, 2007, 2, e1075.
52. Sledge, G.W., Jr. What is targeted therapy? J. Clin. Oncol., 2005, 23, 1614-1615.
53. Wang, K.; Wang, K.; Li, W.; Huang, T.; Li, R.; Wang, D.; Shen, B.; Chen, X. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Acta. Radiol., 2009, 50, 1095-1103.
54. Kampmeier, F.; Niesen, J.; Koers, A.; Ribbert, M.; Brecht, A.; Fischer, R.; Kiessling, F.; Barth, S.; Thepen, T. Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein. Eur. J. Nucl. Med. Mol. Imaging, 2010, 37, 1926-1934.
55. Qi, S.; Miao, Z.; Liu, H.; Xu, Y.; Feng, Y.; Cheng, Z. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors. Bioconjug. Chem., 2012. (E-Pub Ahead Print)
56. Miao, Z.; Ren, G.; Liu, H.; Jiang, L.; Cheng, Z. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors. J. Biomed. Opt., 2010, 15, 036007.
57. Yang, M.; Cheng, K.; Qi, S.; Liu, H.; Jiang, Y.; Jiang, H.; Li, J.; Chen, K.; Zhang, H.; Cheng, Z. Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor pet, optical and mr imaging. Biomaterials, 2013, 34, 2796-2806.
58. Gee, M.S.; Upadhyay, R.; Bergquist, H.; Alencar, H.; Reynolds, F.; Maricevich, M.; Weissleder, R.; Josephson, L.; Mahmood, U. Human breast cancer tumor models: Molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology, 2008, 248, 925-935.
59. Ellis, L.M.; Hicklin, D.J. VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nat. Rev. Cancer, 2008, 8, 579-591.
60. Iqbal, S.; Lenz, H.J. Integration of novel agents in the treatment of colorectal cancer. Cancer Chemother. Pharmacol., 2004, 54 Suppl 1, S32-39.
61. Goodman, V.L.; Rock, E.P.; Dagher, R.; Ramchandani, R.P.; Abraham, S.; Gobburu, J.V.; Booth, B.P.; Verbois, S.L.; Morse, D.E.; Liang, C.Y.; Chidambaram, N.; Jiang, J.X.; Tang, S.; Mahjoob, K.; Justice, R.; Pazdur, R. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. Clin. Cancer Res., 2007, 13, 1367-1373.
62. Kane, R.C.; Farrell, A.T.; Saber, H.; Tang, S.; Williams, G.; Jee, J.M.; Liang, C.; Booth, B.; Chidambaram, N.; Morse, D.; Sridhara, R.; Garvey, P.; Justice, R.; Pazdur, R. Sorafenib for the treatment of advanced renal cell carcinoma. Clin. Cancer Res., 2006, 12, 7271-7278.
63. Backer, M.V.; Levashova, Z.; Patel, V.; Jehning, B.T.; Claffey, K.; Blankenberg, F.G.; Backer, J.M. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat. Med., 2007, 13, 504-509.
64. Cheng, Z.; Wu, Y.; Xiong, Z.; Gambhir, S.S.; Chen, X. Nearinfrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjug. Chem., 2005, 16, 1433-1441.
65. Gao, J.; Chen, K.; Luong, R.; Bouley, D.M.; Mao, H.; Qiao, T.; Gambhir, S.S.; Cheng, Z. A novel clinically translatable fluorescent nanoparticle for targeted molecular imaging of tumors in living subjects. Nano Lett., 2012, 12, 281-286.
66. Cheng, Z.; Levi, J.; Xiong, Z.; Gheysens, O.; Keren, S.; Chen, X.; Gambhir, S.S. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug. Chem., 2006, 17, 662-669.
67. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 1986, 46, 6387-6392.
68. He, X.; Gao, J.; Gambhir, S.S.; Cheng, Z. Near-infrared fluorescent nanoprobes for cancer molecular imaging:Status and challenges. Trends Mol. Med., 2010, 16, 574-583.
69. Babu, R.; Adamson, D.C. Fluorescence-guided malignant glioma resections. Curr. Drug Discov. Technol., 2012, 9, 256-267.
70. Bagalkot, V.; Zhang, L.; Levy-Nissenbaum, E.; Jon, S.; Kantoff, P.W.; Langer, R.; Farokhzad, O.C. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett., 2007, 7, 3065-3070.
71. Muthu, M.S.; Kulkarni, S.A.; Raju, A.; Feng, S.S. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials, 2012, 33, 3494-3501.
72. Schipper, M.L.; Cheng, Z.; Lee, S.W.; Bentolila, L.A.; Iyer, G.; Rao, J.; Chen, X.; Wu, A.M.; Weiss, S.; Gambhir, S.S. microPETbased biodistribution of quantum dots in living mice. J. Nucl. Med., 2007, 48, 1511-1518.
73. Ohnishi, S.; Lomnes, S.J.; Laurence, R.G.; Gogbashian, A.; Mariani, G.; Frangioni, J.V. Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol. Imaging, 2005, 4, 172-181.
74. Frangioni, J.V.; Kim, S.W.; Ohnishi, S.; Kim, S.; Bawendi, M.G. Sentinel lymph node mapping with type-II quantum dots. Methods Mol. Biol., 2007, 374, 147-159.
75. Bradbury, M.S.; Phillips, E.; Montero, P.H.; Cheal, S.M.; Stambuk, H.; Durack, J.C.; Sofocleous, C.T.; Meester, R.J.; Wiesner, U.; Patel, S. Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. Integr. Biol. (Camb), 2013, 5, 74-86.
76. Soltesz, E.G.; Kim, S.; Laurence, R.G.; DeGrand, A.M.; Parungo, C.P.; Dor, D.M.; Cohn, L.H.; Bawendi, M.G.; Frangioni, J.V.; Mihaljevic, T. Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann. Thorac. Surg., 2005, 79, 269-277; discussion 269-277.
77. Thorek, D.; Robertson, R.; Bacchus, W.A.; Hahn, J.; Rothberg, J.; Beattie, B.J.; Grimm, J. Cerenkov imaging - a new modality for molecular imaging. Am. J. Nucl. Med. Mol. Imaging, 2012, 2, 163-173.
78. PA, C. Visible emission of clean liquids by action of γradiation. Doklady Akademii Nauk SSSR, 1934, 451.
79. Robertson, R.; Germanos, M.S.; Li, C.; Mitchell, G.S.; Cherry, S.R.; Silva, M.D. Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys. Med. Biol., 2009, 54, N355-365.
80. Spinelli, A.E.; D'Ambrosio, D.; Calderan, L.; Marengo, M.; Sbarbati, A.; Boschi, F. Cerenkov radiation allows in vivo optical imaging of positron emitting radiotracers. Phys. Med. Biol., 2010, 55, 483-495.
81. Liu, H.; Ren, G.; Miao, Z.; Zhang, X.; Tang, X.; Han, P.; Gambhir, S.S.; Cheng, Z. Molecular optical imaging with radioactive probes. plos one, 2010, 5, e9470.
82. Xu, Y.; Liu, H.; Cheng, Z. Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging. J. Nucl. Med., 2011, 52, 2009-2018.
83. Lewis, M.A.; Kodibagkar, V.D.; Oz, O.K.; Mason, R.P. On the potential for molecular imaging with Cerenkov luminescence. Opt. Lett., 2010, 35, 3889-3891.
84. Ruggiero, A.; Holland, J.P.; Lewis, J.S.; Grimm, J. Cerenkov luminescence imaging of medical isotopes. J. Nucl. Med., 2010, 51, 1123-1130.
85. Ackerman, N.L.; Graves, E.E. The potential for cerenkov luminescence imaging of alpha-emitting radionuclides. Phys. Med. Biol., 2012, 57, 771-783.
86. Hu, Z.; Yang, W.; Ma, X.; Ma, W.; Qu, X.; Liang, J.; Wang, J.; Tian, J. Cerenkov luminescence tomography of aminopeptidase N (APN/CD13) expression in mice bearing HT1080 tumors. Mol. Imaging, 2013, 12, 173-181.
87. Zhong, J.; Tian, J.; Yang, X.; Qin, C. L1-regularized cerenkov luminescence tomography with a sp3 method and ct fusion. Conf. Proc. IEEE Eng. Med. Biol. Soc., 2011, 2011, 6158-6161.
88. Zhong, J.; Qin, C.; Yang, X.; Zhu, S.; Zhang, X.; Tian, J. Cerenkov luminescence tomography for in vivo radiopharmaceutical imaging. Int. J. Biomed Imaging, 2011, 2011, 641618.
89. Spinelli, A.E.; Kuo, C.; Rice, B.W.; Calandrino, R.; Marzola, P.; Sbarbati, A.; Boschi, F. Multispectral Cerenkov luminescence tomography for small animal optical imaging. Opt. Express, 2011, 19, 12605-12618.
90. Liu, H.; Carpenter, C.M.; Jiang, H.; Pratx, G.; Sun, C.; Buchin, M.P.; Gambhir, S.S.; Xing, L.; Cheng, Z. Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: A feasibility experimental study. J. Nucl. Med., 2012, 53, 1579-1584.
91. Kothapalli, S.R.; Liu, H.; Liao, J.C.; Cheng, Z.; Gambhir, S.S. Endoscopic imaging of cerenkov luminescence. Biomed Opt. Express, 2012, 3, 1215-1225.
92. Xu, Y.; Liu, H.; Chang, E.; Jiang, H.; Cheng, Z. Cerenkov Luminescence Imaging (CLI) for cancer therapy monitoring. J. Vis. Exp., 2012, e4341.
93. Holland, J.P.; Normand, G.; Ruggiero, A.; Lewis, J.S.; Grimm, J. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions. Mol Imaging, 2011, 10, 177-186, 171-173.
94. Jeong, S.Y.; Hwang, M.H.; Kim, J.E.; Kang, S.; Park, J.C.; Yoo, J.; Ha, J.H.; Lee, S.W.; Ahn, B.C.; Lee, J. Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: Initial feasibility study. Endocr. J., 2011, 58, 575-583.
95. Hu, Z.; Ma, X.; Qu, X.; Yang, W.; Liang, J.; Wang, J.; Tian, J. Three-dimensional noninvasive monitoring iodine-131 uptake in the thyroid using a modified Cerenkov luminescence tomography approach. plos one, 2012, 7, e37623.
96. Liu, H.; Zhang, X.; Xing, B.; Han, P.; Gambhir, S.S.; Cheng, Z. Radiation-luminescence-excited quantum dots for in vivo multiplexed optical imaging. Small, 2010, 6, 1087-1091.
97. Spinelli, A.E.; Ferdeghini, M.; Cavedon, C.; Zivelonghi, E.; Calandrino, R.; Fenzi, A.; Sbarbati, A.; Boschi, F. First human Cerenkography. J. Biomed. Opt., 2013, 18, 20502.
98. Liu, H.; Ren, G.; Liu, S.; Zhang, X.; Chen, L.; Han, P.; Cheng, Z. Optical imaging of reporter gene expression using a positronemission- tomography probe. J. Biomed. Opt., 2010, 15, 060505.